Skip to Content

Ovarian Cancer Low Risk Study

Should women be screened for ovarian cancer?

We hope to answer this question with the Ovarian Cancer Low Risk Study. About 25,000 women in the U. S. are diagnosed with ovarian cancer each year. Most don’t have any symptoms until the disease is advanced. Currently, MD Anderson does not recommend routine screening for ovarian cancer.

Are there ovarian cancer screening tests available?

Currently, there are no effective tests to detect ovarian cancer at its earliest stages, but if ovarian cancer is found early, the chances of cure increase dramatically. MD Anderson researchers hope this study will result in more effective ovarian cancer screening methods.

What is the purpose of this study?

MD Anderson researchers are evaluating a blood (CA-125) and urine test that may be helpful in the early detection of ovarian cancer in healthy, post-menopausal women.

Here’s how it works.


  • conduct a telephone interview with you
  • perform a blood test (annually or quarterly)
  • request that you complete a medical history questionnaire
  • perform a transvaginal ultrasound (for some, but not all participants)

Am I eligible?

You’re eligible to participate if you:

  • are between the ages of 50 and 74
  • are post-menopausal (no period for one year or longer)
  • have not received cancer treatment for at least 12 months

What are the benefits of participating?

Participants will:

  • receive ovarian cancer screening tests at no cost
  • contribute valuable information to medical research which may benefit future generations

How do I find out more or enroll?

For questions or to join, call 713-563-6728 and ask for study ID01-022, or email

Who are the specialists involved in this study?

Karen H. Lu, Ph.D., study chair for the Low Risk Ovarian Cancer Study

Will my information be kept confidential?

All information that you provide, as well as your blood sample results, will be completely confidential. No one outside this study may have access to your information without your permission.

© 2015 The University of Texas MD Anderson Cancer Center